Rui Peng
- Biomedical Engineering top 0.1%
- Molecular Biology top 2%
- Materials Chemistry top 1%
- Immunology top 0.5%
- Biomaterials top 0.2%
- Co-authors
- Zhuang LiuLigeng XuJun XuChao WangQian ChenChao LiangXiaoqi SunYu Chao
- Topics
- Nanoplatforms for cancer theranostics (23 papers)Immunotherapy and Immune Responses (16 papers)RNA Interference and Gene Delivery (14 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Rui Peng
112 papers receiving 10.3k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Biomedical Engineering 6.8k
- Molecular Biology 3.5k
- Materials Chemistry 3.1k
- Immunology 2.5k
- Biomaterials 2.0k
Countries citing papers authored by Rui Peng
This map shows the geographic impact of Rui Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Peng more than expected).
Fields of papers citing papers by Rui Peng
This network shows the impact of papers produced by Rui Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Peng. The network helps show where Rui Peng may publish in the future.
Co-authorship network of co-authors of Rui Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Rui Peng. A scholar is included among the top collaborators of Rui Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Peng. Rui Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 16 | |
| 9 | Oncolytic mineralized bacteria as potent locally administered immunotherapeuticsbreakdown → | 59 |
| 10 | 4 | |
| 11 | 1 | |
| 12 | 17 | |
| 13 | 25 | |
| 14 | 2 | |
| 15 | 3 | |
| 16 | 1 | |
| 17 | 5 | |
| 18 | A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapybreakdown → | 459 |
| 19 | The prognostic value of preoperative serum HDL cholesterol in patients with resectable acral melanoma | 1 |
| 20 | Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma | 1 |
About Rui Peng
Rui Peng is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 118 papers that have together received 10.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (23 papers), Immunotherapy and Immune Responses (16 papers) and RNA Interference and Gene Delivery (14 papers). The work is most often cited by research in Biomaterials (2.0k citations), Biomedical Engineering (6.8k citations) and Immunology (2.5k citations). Rui Peng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhuang Liu, Ligeng Xu, Jun Xu, Chao Wang, Qian Chen, Chao Liang, Xiaoqi Sun, Yu Chao, Liangzhu Feng and Guangbao Yang. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.